Comments

Cassava Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

SAVANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.05

0.179.04%

At close: -

$2.18

0.136.35%

After Hours: 7:59 PM EDT

Cassava Sciences (SAVA) Forecast

News Earnings Cassava Sciences (SAVA) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cassava Sciences Stock Price, Quotes and Forecasts | NASDAQ:SAVA | Benzinga

Explore Cassava Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SAVA.

Open	$1.89
Close	$2.05
Volume / Avg.	1.73M / 1.56M
Day Range	$1.82 - $2.06
52 Wk Range	1.15 - 42.20
Market Cap	$105.32M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	20.99%
Days to Cover	11.96

Recent News

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus to potential seizure treatments.

Vandana Singh

Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.

Erica Kollmann

Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Michael Cohen

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.89
Close	$2.05
Volume / Avg.	1.73M / 1.56M
Day Range	$1.82 - $2.06
52 Wk Range	1.15 - 42.20
Market Cap	$105.32M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	20.99%
Days to Cover	11.96

About Cassava Sciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific ap...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cassava Sciences (SAVA) stock?

You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.

View our list of the best stock brokerages

Who are Cassava Sciences (SAVA) competitors?

Other companies in Cassava Sciences’s space includes: Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Universe Pharmaceuticals (NASDAQ:UPC), Neumora Therapeutics (NASDAQ:NMRA) and Aardvark Therapeutics (NASDAQ:AARD).

What is the forecast, or price target, for Cassava Sciences (SAVA) stock?

Cassava Sciences has a consensus price target of $51.00.

What is the current price for Cassava Sciences (SAVA)?

The stock price for Cassava Sciences (NASDAQ: SAVA) is $2.1801 last updated May 15, 2025 at 7:59 PM EDT.

Does Cassava Sciences (SAVA) pay a dividend?

A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

Cassava Sciences’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Cassava Sciences (SAVA) going to split?

There is no upcoming split for Cassava Sciences.

What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.